Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 212,352 shares at $2.58 ($552K) on 2023-05-01, disclosed to the SEC on 2023-05-03.
Scheduled sale ($552k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.58 | 77,424 | $200K | 36.2% |
| 2 | $2.58 | 77,424 | $200K | 36.2% |
| 3 | $2.65 | 28,752 | $76K | 13.8% |
| 4 | $2.65 | 28,752 | $76K | 13.8% |
| Total | $2.60 avg | 212,352 | $552K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |